Finance

Lists
IMCR:NASDAQ
Immunocore Holdings PLC - ADR
$ 29.39
+1.03%
(+0.30) 1D
$ 29.39
0.00% (0.00)
After hours
Closed: 10-р сарын 9, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMCR...
Open
$ 29.06
High
$ 29.73
Low
$ 29.03
Mkt. cap
1.54 тэрбум
Avg. vol.
404.95 мян
Volume
452.84 мян
52-wk high
$ 40.71
52-wk low
$ 27.56
EPS
-$ 0.37
Beta
0.81
Shares outstanding
51.50 сая
No. of employees
524
Open
$ 29.06
High
$ 29.73
Low
$ 29.03
Mkt. cap
1.54 тэрбум
Avg. vol.
404.95 мян
Volume
452.84 мян
52-wk high
$ 40.71
52-wk low
$ 27.56
EPS
-$ 0.37
Beta
0.81
Shares outstanding
51.50 сая
No. of employees
524
News stories
From web sources and news partners
Profile
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
About Immunocore Holdings PLC - ADR
CEOBahija Jallal
Employees524
Founded2008
Headquarters-
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to IMCR in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IMCR in the last 3 months.
Highest
Current $ 29.39
$ 100.00 (+240.25%)
Average
$ 62.83 (+113.78%)
Lowest
$ 35.00 (+19.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
$ 100.00
+240.3%
09/21/2026
Jessica Fye
J.P. Morgan
Buy
Initiated
$ 50.00
+70.1%
08/21/2026
Sean Laaman
Morgan Stanley
Hold
Maintained
$ 43.00
+46.3%
08/07/2026
Rajan Sharma
Goldman Sachs
Buy
Maintained
$ 74.00
+151.8%
08/06/2026
Graig Suvannavejh
Mizuho Securities
Hold
Maintained
$ 35.00
+19.1%
08/07/2026
Gil Blum
Needham
Buy
Maintained
$ 75.00
+155.2%
08/06/2026
Unknown Analyst
Guggenheim
Hold
Maintained
-
-
05/06/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
$ 60.00
+104.2%
05/06/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$ 86.00
+192.6%
04/20/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Maintained
$ 60.00
+104.2%
04/14/2026
Faisal Khurshid
Jefferies
Hold
Downgraded
$ 33.00
+12.3%
03/15/2026
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
-$ 0.02 / $ 0.02
-195.65%miss
Revenue / Est. (USD)
115.93 сая / 110.92 сая
+4.51%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
103.69 сая
104.48 сая
106.68 сая
115.93 сая
Cost of goods sold
71.08 сая
81.52 сая
434.00 мян
75.03 сая
Cost of revenue
71.08 сая
81.52 сая
434.00 мян
75.03 сая
Research and development expenses
-
-
61.11 сая
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.78 сая
42.64 сая
37.85 сая
43.89 сая
Operating expense
39.78 сая
22.92 сая
98.96 сая
43.89 сая
Total operating expenses
110.86 сая
104.44 сая
99.40 сая
118.92 сая
Operating income
-7.17 сая
37.00 мян
7.28 сая
-3.00 сая
Other non operating income
5.06 сая
-15.22 сая
-
-
EBT including unusual items
304.00 мян
-15.79 сая
13.27 сая
-514.00 мян
EBT excluding unusual items
304.00 мян
-15.79 сая
11.50 сая
-3.58 сая
Income tax expense
481.00 мян
14.27 сая
301.00 мян
294.00 мян
Effective tax rate
158.22%
-90.33%
2.27%
-57.20%
Other operating expenses
-
-19.73 сая
-
-
Net income
-177.00 мян
-30.06 сая
12.97 сая
-808.00 мян
Net profit margin
-0.17%
-28.77%
12.16%
-0.70%
Earnings per share
-
-0.60
0.25
-0.02
Interest and investment income
4.12 сая
3.91 сая
3.42 сая
3.58 сая
Interest expense
-3.04 сая
-3.05 сая
-3.05 сая
-3.06 сая
Net interest expenses
1.08 сая
853.00 мян
367.00 мян
520.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.37 сая
871.00 мян
8.23 сая
-1.97 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс